Adebayo A.

Adebayo (Sam) A. is a prominent entrepreneur and thought leader in the pharmaceutical industry, serving as the Founder and Group CEO of RxAll Inc., a pioneering company in in-situ drug authentication. Adebayo also founded StorsApp, Inc., which operates under the RxAll umbrella. As a participant in the G-Startup Worldwide Indonesia 2017 Batch, Adebayo demonstrated a commitment to innovation and entrepreneurship. Previous consulting experience includes a role at The Boston Consulting Group (BCG), and Adebayo held the position of Director of Business Development at Lusoy Investments Limited. Currently pursuing education at Harvard University and Harvard Kennedy School from July 2022 to May 2024, Adebayo is focused on advancing knowledge and skills in the business and public policy sectors.